DGAP-News: Newron’s commercialization partner Zambon and Valeo Pharma announce the launch of Onstryv(R) (safinamide) for Parkinson’s disease in Canada

DGAP-News: Newron’s commercialization partner Zambon and Valeo Pharma announce the launch of Onstryv(R) (safinamide) for Parkinson’s disease in Canada
DGAP-News: Newron Pharmaceuticals S.p.A. / Key word(s): Market launch Newron's commercialization partner Zambon and Valeo Pharma announce the launch of Onstryv(R) (safinamide) for Parkinson's ... read more
Source: Bing NewsPublished on 2019-07-10